Phase 1 Cataract Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
NPI-002 Intravitreal Implant for the Delay of Cataract Progression
Cataract
Nacuity Pharmaceuticals, Inc.30 enrolled1 locationNCT05026632
Recruiting
Phase 1
Safety and Tolerability of EO2002
Endothelial Cell Loss, CornealCataract
Asociación para Evitar la Ceguera en México32 enrolled1 locationNCT05587205
Recruiting
Phase 1Phase 2
Transdermal Microneedle Lignocaine Delivery Versus EMLA Patch for Topical Analgesia Before Venepuncture Procedure To Adults in Clinical Setting
CataractGlaucomaOphthalmological Disorder
Universiti Kebangsaan Malaysia Medical Centre154 enrolled1 locationNCT05694858
Recruiting
Phase 1
Clinical Application Comparison of Two Femtosecond Laser Systems
Cataract
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled1 locationNCT06754358
Recruiting
Phase 1Phase 2
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
Cataract
Inder Paul Singh, M.D.94 enrolled2 locationsNCT06681688